01 1Cipla
02 1Guangdong Raffles PharmaTech Co Ltd
03 1Hetero Drugs
04 1Maithri Drugs
05 1Shenzhen HwaGen Pharmaceutical
01 2China
02 3India
01 1Active
02 4Blank
01 5Blank
01 5Blank
01 5Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37939
Submission : 2023-03-20
Status : Active
Type : II
NDC Package Code : 53104-7740
Start Marketing Date : 2023-11-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
We have 5 companies offering Cabotegravir
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?